A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

NCT07520162 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: Tezepelumab

Sponsor

AstraZeneca